Jonathan Parr
@jonbparr
Followers
283
Following
123
Media
23
Statuses
198
Asst Prof @UNC focused on global health and ID molecular epi @IDEELlabs @uncglobalhealth | @Stanford @UVA @Harvard @BrighamMedRes alum | Views my own
Chapel Hill, NC
Joined April 2020
Our new #PaluSeq project to establish #malaria molecular surveillance capacity in DR #Congo officially launched yesterday! Thanks @gatesfoundation and PNLP for supporting this important work. @EsteeTorok
2
7
24
Great having you with us in Kinshasa @EsteeTorok. Thanks to @gatesfoundation for supporting our work in the DRC. Nous sommes ensemble ! .@uncglobalhealth @JBaileyOmics.
Wonderful to visit grantees and partners working together on the #paluseq project in DRC including MOH, PNLP, PNLS @inrb_kinshasa @SanruAsbl @Esp_Kin @ucbukavu @BahizireEsto @UNC @IDEELlabs @jonbparr 🇨🇩🤝🇨🇩
0
5
15
Turn old photos into videos and see friends and family come to life. Try Grok Imagine, free for a limited time.
709
1K
5K
Thrilled to work together to investigate emerging drug-resistant #malaria strains in #Ethiopia with partners @EPHIEthiopia as well as @JBaileyOmics @NotreDame @ICE_Malaria @uncglobalhealth.
0
2
14
RT @AshenafiA: MAREE launched with a grace at EPHI!.@EPHIEthiopia @IDEELlabs @UNC @IsabelaGerGyu @jonbparr @abebe_fola @FMoHealth @BrownUni….
0
2
0
RT @UNC_ID: 📢Please share: #TarHealTuesday is one week away! Join us as we fundraise for #infectious #disease patients in need. One gratefu….
0
3
0
Thanks @uncglobalhealth & @TheLancet for featuring our commentary. @KThriemer et al released results of a multi-country RCT showing efficacy of linking vivax radical cure to falciparum #malaria treatment. Findings relevant to countries affected by both parasite spp. @AshenafiA.
Ashenafi Assefa and @jonbparr @IDEELlabs assess the pros and cons of a new strategy to simplify #malaria treatment, both published in @TheLancet .@GillingsGlobal @UNCpublichealth.
0
0
7
Great to work with you on this, @AshenafiA, and to see creative approaches being developed to help #endmalaria. @uncglobalhealth @IDEELlabs @EPHIEthiopia.
I have engaged in discussions surrounding radical cure by Premaquine, G6PD testing, and their programmatic implications for several years in my career. It is with humility that I/we reflect on this issue in light of the outstanding work published on Nov.15.
0
1
4
Nice work @deusishe @AlfredoMayor5, Josh, and Bob! Important and easy to digest.
🚨Publication alert! .“Sampling for malaria molecular surveillance” was just published in @TrendsParasitol. This review unpacks the essentials for robust malaria molecular surveillance (MMS) study design with a focus on the sampling approach [1/5].🩸➡️🧬
0
1
8
RT @deusishe: A big thanks to all who supported us to get to this important milestone. Please enjoy our new paper which is finally out. We….
medrxiv.org
Background Emergence of artemisinin partial resistance (ArtR) in Plasmodium falciparum in East Africa is a growing threat to the efficacy of artemisinin combination therapies (ACT) and the global...
0
19
0
RT @uncglobalhealth: IGHID attracts people driven to make big change! From principal investigators and grant managers to regulatory special….
0
2
0
Thanks @uncglobalhealth for featuring our work in @IDEELlabs. Such a pleasure to work with this team.
globalhealth.unc.edu
Researchers in the Infectious Disease Epidemiology and Ecology Lab (IDEEL) at UNC are process driven investigators with a unique comradery, working in 20+ countries to improve basic understandings of...
0
3
14
RT @uncglobalhealth: Congrats to Dr. Jessica Lin who will study human mobility and its impact on the elimination of #malaria in #Zanzibar….
0
2
0
RT @MESAmalaria: 🦟❗ Malaria parasites in Ethiopia are developing resistance to drugs and diagnostics. Join @malariagenomics on 31 October,….
0
3
0
RT @Kristin_Banek: NEW PUBLICATION ALERT 🚨 Describing the Epidemiology of P. malariae and P. ovale spp. in Kinshasa Province, Democratic R….
nature.com
Nature Communications - Non-falciparum malaria may cause a significant disease burden in highly endemic regions, but epidemiological data is limited. In this study, the authors estimate the...
0
2
0
Just out ! A sobering paper on #malaria in the DR #Congo led by @RachelSendor__, w/ colleagues @esp_unikin. We set out to eval other species… but I just can’t get over the falciparum rates (>2/3 infected!) DRC needs sustained support to #Endmalaria.
0
8
18
Thanks @uncglobalhealth for featuring our recent @NatureMicrobiol paper led by @abebe_fola on #malaria parasites capable of escaping first-line drugs & diagnostics in Ethiopia. Paper here: @IDEELlabs @EPHIEthiopia @JBaileyOmics.
0
1
6
Wholeheartedly agree. Thanks @ASTMH for bringing us together. These types of meetings and connections are invaluable. #TropMed23.
One peculiarity of Tropmed is that it gives the opportunity for colleagues in different walks of life and space but similar interests sit together to discuss burning and common issues: MOH, EPHI, UNC,Brown and CDPH.@FMoHealth @EPHIEthiopia @IDEELlabs @ASTMH @jonbparr @EsteeTorok
0
0
7
RT @malariagenomics: Out now in @TrendsParasitol 📄. Read about the opportunities and challenges in deploying nanopore sequencing technologi….
0
11
0
Only Bob Verity from @ImperialMalaria can keep an entire room engaged during a talk on statistical power. Great talk on #malaria study sample sizes at the @gatesfoundation malaria genomics convening in Dakar.
0
5
40
Important article just out in @NEJM describing increasing numbers of #malaria parasites with resistance to first-line drugs in Eritrea. These and our findings in Ethiopia are cause for concern in the Horn of Africa.
nejm.org
Although the clinical efficacy of antimalarial artemisinin-based combination therapies in Africa remains high, the recent emergence of partial resistance to artemisinin in Plasmodium falciparum on ...
1
15
27